Macular degeneration trials in Puerto Rico

5 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

  Where

  Arecibo

  Age

  50 years and over

  People

  272 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07441642 · EU 2025-523704-77-00
• Phase 3Taking people
  Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

  Where

  Arecibo

  Age

  50 years and over

  People

  561 worldwide

  Run by

  AbbVie

  See details and how to joinNCT07007065 · EU 2024-512298-28-00
• Phase 2/3Taking people
  A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

  Where

  San Juan

  Age

  50 years and over

  People

  960 worldwide

  Run by

  EyeBiotech Ltd.

  See details and how to joinNCT07440225
• Phase 1/2Taking people
  4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

  Where

  Arecibo

  Age

  50 years and over

  People

  215 worldwide

  Run by

  4D Molecular Therapeutics

  See details and how to joinNCT05197270
• Phase 1Taking people
  Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants

  Where

  Arecibo

  Age

  50 years and over

  People

  54 worldwide

  Run by

  Regeneron Pharmaceuticals

  See details and how to joinNCT07230834 · EU 2025-521758-40-00